Controlled-release formulations

作者: Siva Rama K. Nutalapati , Kristin Arnold , Ishari Piya

DOI:

关键词:

摘要: Disclosed herein are controlled-release formulations which exhibit substantially zero-order release kinetics. The include a core comprising active agent and wax excipient coated with an extended-release coating. formulation optionally includes immediate-release portion in the form of, for example, coating disposed on at least of core. Further disclosed fexofenadine/pseudoephedrine combination formulations, no food effect.

参考文章(68)
Francois Regnier, Alfuzosine compositions and use ,(1986)
Sibel Ucpinar, Richard Ting, Felix S. Lai, Christopher A. Simpson, Bernard Lee, Enteric coated hydrophobic matrix formulation ,(2008)
Fu-Yung Lin, Fang-Hsiung Hsiao, Ya-Ching Chang Chien, Sustained release alfuzosin hydrochl formulation and method for their production ,(2006)
Venkat Arvind Vakati, Srinivas Arutla, Sathya Narayana Vemula, Rajesh Gunde Rao Kulkarni, Uma Devi Palaparthi, Sarveswara Rao Srirama Mandavilli, Nookaraju Venkata Sreedharala, Sustained delivery alfuzosin compositions ,(2006)
Dirk Kramer, Marc Fischer, Mathias Scheer, Helene Rey, Alfuzosin tablets and synthesis ,(2005)
Monique Berwaer, Michaël Boonen, Caroline Goffin, Domenico Fanara, Michel Deleers, Novel Pharmaceutical Compositions Comprising Levetiracetam ,(2007)
Hans-Ulrich Petereit, Rosario Lizio, Manfred Assmus, Herna Ravishankar, Multilayer dosage form comprising a matrix that influences release of a modulatory substance ,(2004)
Narayanan Badri Viswanathan, Ashok Rampal, Sankar Ramakrishnan, Rajeev Singh Raghuvanshi, Sustained release compositions containing alfuzosin ,(2003)
Gianpiero Ventimiglia, Pietro Allegrini, Graziano Castaldi, Fexofenadine base polymorphic forms ,(2005)